Abstract:The microbially-derived short-chain fatty acid butyrate is a central inhibitor of inflammatory innate and adaptive immune responses. Emerging evidence suggests that butyrate induces differentiation of IL-10-producing (IL-10 + ) regulatory B cells. However, the underlying mechanisms of butyrate-driven modulation of B cell differentiation are not fully defined. Given the dominant role of regulatory plasma cells (PCs) as the main source of anti-inflammatory cytokines including IL-10 and the observation that butyrate also induces the differentiation of PCs, we here investigated the effect of the microbial metabolite butyrate on the induction of regulatory IL-10 + PCs and underlying mechanisms. Here we show that butyrate induces the differentiation of IL-10 + IgM + PCs. Ex vivo , butyrate, but hardly propionate, another microbially-derived short-chain fatty acid, induced the differentiation of IL-10 + IgM + CD138 high PCs from isolated splenic murine B cells. In vivo , administration of butyrate via drinking water or by daily intraperitoneal injection increased the number of IL-10 + IgM + CD138 high PCs in the spleens of Ovalbumin (Ova)/complete Freund’s adjuvant-immunized mice. The induction of these regulatory PCs was associated with an increase of anti-Ova IgM, but a reduction of anti-Ova class-switched pathogenic IgG2b serum antibodies. Based on the knowledge that butyrate inhibits histone deacetylases (HDACs) thereby increasing histone acetylation, we identified here that HDAC3 inhibition was sufficient to induce PC differentiation and IL-10 + expression. Furthermore, reduced mitochondrial superoxide levels following butyrate treatment and HDAC3 inhibition were necessary for PC differentiation, but not IL-10 expression. In summary, the microbial metabolite butyrate promotes the differentiation of IgM + PCs and their expression of IL-10. HDAC3 inhibition may be involved as an underlying pathway for both PC differentiation and IL-10 expression, while reduced mitochondrial superoxide levels are crucial only for PC differentiation. The induction of regulatory IL-10 + IgM + PCs and the inhibition of class switching to antigen-specific pathogenic IgG subclasses might represent important pathways of butyrate to limit inflammation.

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

Butyrate Attenuates Intestinal Inflammation in Crohn’s Disease by Suppressing Pyroptosis of Intestinal Epithelial Cells Via the Cgsa-Sting-nlrp3 Axis

Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation

Butyrate Inhibits Interleukin-17 and Generates Tregs to Ameliorate Colorectal Colitis in Rats

Butyrate Induces Intestinal Epithelial Cell to Express Thrombospondin 1 and Suppress Intestinal Mucosal Inflammation

Microbial metabolite butyrate facilitates M2 macrophage polarization and function

Butyrate Functions in Concert with Myeloid-Derived Suppressor Cells Recruited by CCR9 to Alleviate DSS-induced Murine Colitis.

Butyrate alleviates murine colitis by promoting the expansion of myeloid-derived suppressor cells

Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate

Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity

Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

Gut microbiota-derived lipid metabolites facilitate regulatory T cell differentiation

Microbiota-derived butyrate inhibits cDC development via HDAC inhibition, diminishing their ability to prime T cells

Microbial metabolite butyrate promotes induction of IL-10+IgM+ plasma cells

Gut Microbiota Defines Functional Direction of Colonic Regulatory T Cells with Unique TCR Repertoires

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro

Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota